Membrane pump usage condition detection

Information

  • Patent Grant
  • 12163513
  • Patent Number
    12,163,513
  • Date Filed
    Tuesday, January 31, 2017
    8 years ago
  • Date Issued
    Tuesday, December 10, 2024
    2 months ago
Abstract
A membrane pump usage condition detection system and a method of determining a membrane pump usage condition. The membrane pump usage condition detection system comprises a membrane pump defining a flow path arranged to be opened and closed by at least one valve, a measuring device; a comparator; and a signal generator. The measuring device is configured to determine an electrical characteristic between two points on the flow path of the membrane pump, one point arranged upstream of the at least one valve and the other point arranged downstream of the at least one valve. The measuring device measures the electrical characteristic when the at least one valve is closed. The comparator is configured to monitor the electrical characteristic. The signal generator is arranged to provide an output signal when the electrical characteristic is indicative of a membrane pump usage condition.
Description

This application is a National Stage Entry entitled to and hereby claiming priority under 35 U.S.C. §§ 365 and 371 to corresponding PCT Application No. PCT/GB2017/050235, filed Jan. 31, 2017 entitled “Membrane Pump Usage Condition Detection”, which in turn claims priority to G.B. Patent Application No.: 1602391.3, filed Feb. 10, 2016, entitled the same. The disclosures of the above applications are incorporated herein by reference in their entireties.


The present invention relates to a membrane pump usage condition detection system and a method of determining a membrane pump usage condition.


Fluid pumps, for example blood pumps for the extracorporeal circulation of blood are used in a number of medical applications, for example in hemodialysis, and haemodiafiltration.


In hemodialysis machines, it is known to use a disposable cartridge comprising a rigid frame defining fluid pathways and chambers and a flexible membrane covering a surface of the cartridge. The cartridge is loaded into a hemodialysis machine, where pressure, typically pneumatic pressure, exerted on the outside surface of the flexible membrane, causes the membrane to move back and forth. This back and forth action in the region of a chamber acts as a fluid pump, which is thus often referred to as a membrane pump. Such a machine is disclosed in WO 2013/121163, the contents thereof are hereby incorporated by reference.


The movement may also be used to mix two or more fluids in a chamber, such as bicarbonate and acid to create dialysate.


The movement of the flexible membrane may also be used to open and close valves defined in the rigid frame of the disposable cartridge. Such a system is disclosed in WO 2013/110919, the contents thereof are hereby incorporated by reference.


Because of its use in hemodialysis, in pumping and mixing fluids, the cartridge may be referred to as a haemodialysis pulsatile pumping cartridge. Such a disposable cartridge is typically made of a rigid frame of polyethylene and a flexible membrane of polyvinyl chloride (PVC).


In use, the disposable cartridge is loaded in a hemodialysis machine and undergoes repeated deformations in the localised regions of the pump chambers, mixing chambers and valves. In a typical cycle, the machine will perform a priming stage, a treatment stage, including flow balance and ultrafiltration stages following by a purge stage.


Such a dialysis machine relies on volumetric control. Dosing and mixing of fluids is controlled by the volume of the pump chambers which in turn is affected by the flexibility of the membrane. The specific flexibility of the membrane is therefore essential to the accurate running of the dialysis machine. Similarly, flow of fluids into and out of the pump chambers is controlled by inlet and outlet valves which rely on the deformation of the flexible membrane.


Repeated deformations gradually cause plastic deformation of the flexible membrane. Thus the disposable cartridges may be engineered to withstand a specific cycle loading, along with a reserve factor. Once used, the disposable cartridge is disposed of and should not be used again.


Re-use of a cartridge designed for a single cycle, or re-use of a cartridge designed for a specific number of cycles, beyond that number of cycles, may reduce the efficacy of treatment and has the potential to cause damage to the dialysis machine.


Given the typical make-up of the disposable cartridge, and that a typical cycle ends with a purge stage that washes and empties the cartridge to remove any residual fluids, a used cartridge does not visibly show any distinct features, as compared to an unused cartridge. Therefore there is a risk of cartridge re-use, either deliberate or accidental.


Valve leak systems are installed in the dialysis machine to detect if any of the valves on the dialysis cartridge are not closing properly, such that there is a leak of fluid through the valve. The valve leak system comprises first and second conductivity electrodes arranged upstream and downstream of the valve respectively. A conductivity measurement is taken across the electrodes when the valve is closed. For a normally functioning valve, a low conductivity, or indeed no conductivity should be detected when the valve is closed. If a valve is leaking however, a high conductivity is detected, as the leaking fluid carries the charge through the valve, between the first and second conductivity electrodes.


The present invention aims to provide a membrane pump usage condition detection system and a method of determining a membrane pump usage condition and that mitigates one or more of the above problems.


According to a first aspect of the present invention, there is provided a membrane pump usage condition detection system comprising a membrane pump defining a flow path arranged to be opened and closed by at least one valve, a measuring device, a comparator and a signal generator, wherein the measuring device is configured to determine an electrical characteristic between two points on the flow path of the membrane pump, one point arranged upstream of the at least one valve and the other point arranged downstream of the at least one valve, whereby the measuring device measures the electrical characteristic when the at least one valve is closed, and wherein the comparator is configured to monitor the electrical characteristic; and the signal generator is arranged to provide an output signal when the electrical characteristic is indicative of a membrane pump usage condition.


Thus the system provides an output signal characterising the membrane pump usage condition using data from a valve leak system. This may give an operator of a cartridge incorporating the membrane pump, information concerning the overall condition of the cartridge. As data from the valve leak system is used, the membrane pump usage condition detection system requires no additional hardware.


The electrical characteristic may be one of conductance, impedance or capacitance or any other electrical characteristic measurable across the valve.


The detection system may further comprise a processor arranged to receive the output signal. The output signal may be stored in the processor. Thus further analysis may be performed on the identified characteristic. Patterns of deliberate or accidental cartridge re-use may then be monitored.


The membrane pump may be provided on a cartridge. The membrane pump usage condition may be indicative of a cartridge usage condition.


The processor may calculate the specific number of cartridge uses from the electrical characteristic indicative of the membrane pump usage condition.


The output signal may be an error message preventing further cartridge use. This prevents deliberate or accidental cartridge re-use, or re-use of a cartridge beyond a specified number of uses. This may be notified to the user/operator of the dialysis machine in the form of an audible or visual alarm.


The comparator may compare the electrical characteristic with a pre-determined threshold value. Alternatively, the comparator may compare the electrical characteristic with a dynamic threshold value.


The output signal may be provided when the electrical characteristic is above the threshold value. Alternatively, the output signal is provided when the electrical characteristic falls below the threshold value.


The output signal may be an alarm indicating a net fluid removal error. A valve leak could cause net fluid removal error by not fully filing up or emptying the pump with dialysate. Hence, when a valve leak is detected by measuring the frequency an alarm is generated to stop treatment.


The processor may be programmed to permit a set number of cartridge re-uses.


The measuring device may be a pair of electrodes. Alternatively the measuring device may be a pair of capacitance probes.


According to a second aspect of the present invention, there is provided a method of determining a membrane pump usage condition comprising the steps of: providing a dialysis machine including a cartridge having a deformable membrane, the cartridge and deformable membrane together defining a membrane pump, the membrane pump defining a flow path arranged to be opened and closed by at least one valve, a measuring device, a comparator; and a signal generator, configuring the measuring device for determining an electrical characteristic between two points on the flow path of the membrane pump, one point arranged upstream of the at least one valve and the other point arranged downstream of the at least one valve, operating the dialysis machine through a cycle, measuring the electrical characteristic whenever the at least one valve is closed, monitoring the electrical characteristic throughout the cycle using the comparator, providing an output signal when the electrical characteristic is indicative of a membrane pump usage condition.


Thus the method of the present invention provides a measure of cartridge deterioration (and re-use) using the data output of the existing valve leak detection system.


The electrical characteristic may be one of conductance, impedance or capacitance. The cycle may include at least one of a priming stage, a treatment stage, and a purge stage.


The membrane pump usage condition may be indicative of a cartridge usage condition.


The step of determining the membrane pump usage condition includes recording a characteristic value above a limit value. Alternatively, the step of determining the membrane pump usage condition may include recording a series of characteristic values above a limit value.


The characteristic value may be a decay rate of the valve leak frequency following a spike in the valve leak frequency. The characteristic values are observed in the data of the valve leak detection system. The so-called background levels change with cartridge re-use. The background level of the valve leak detection system is observed to spike to higher levels during cartridge re-use. The background level of the valve leak detection system is observed to spike to higher levels and then more rapidly decay during cartridge re-use.


The decay rate of the valve leak frequency following a spike in the valve leak frequency may be indicative of a specific number of cartridge uses. Thus the specific number of cartridge uses may be determined.


The characteristic value may be the mean, median or modal average valve leak frequency during the cycle. This value may be compared to a signature value for a specific cartridge, providing an indication of the level of cartridge re-use.


The cartridge usage condition may be determined using a processor provided on the dialysis machine.


The valve leak frequency may be recorded at a sample rate of 1 sample a second during the cycle. Alternatively, the valve leak frequency may be recorded at an intermittent sample rate during the cycle.





Embodiments of the present invention will now be described, by way of example only, and with references to the accompanying drawings, in which:



FIG. 1 is a schematic cross-sectional view of a dialysis machine;



FIG. 2 is a perspective view of a cartridge of the dialysis machine of FIG. 1;



FIG. 3 is a plan view of the cartridge of FIG. 2;



FIG. 4 is a perspective view of a sensing electrode;



FIG. 5 is a partial cross-sectional view of the cartridge taken at line A-A of FIG. 3;



FIG. 6 is a schematic of the fluid flowpath of the sensing arrangement for flow balance pump “B”.



FIG. 7 is a valve leak detection frequency profile of a valve on a cartridge undergoing a typical cycle;



FIG. 8 is a valve leak detection frequency profile of a valve on a cartridge undergoing a sequence of cycles; and



FIG. 9 is a valve leak detection frequency profile of a valve on a cartridge undergoing a sequence of cycles, each cycles omitting the purging stage.





DIALYSIS MACHINE

A cross section of a dialysis machine 10 is shown schematically in FIG. 1. The dialysis machine 10 has machine body 22. The machine body 22 houses pneumatic actuators 24 and a controller 26. The dialysis machine 10 includes a first platen 12 and a second platen 14. The first and second platens 12, 14 together define a cavity into which a cartridge 30 is received in a known manner.


The cartridge 30 (see FIGS. 2 and 3) has a rigid body 31 covered by a flexible membrane 32, providing a machine facing surface 33. The cartridge 30 in part embodies pump chambers and valves. In this case, the chambers are flow balance pump chamber “A” 40, flow balance pump chamber “B” 42, dialysate mixing pump chamber 44, acid mixing pump chamber 46 and ultrafiltration pump chamber 48. The flow balance pump chamber “A” 40 and flow balance pump chamber “B” 42 each have two inlet valves 50 and two outlet valves 52.


The pneumatic operation of each of the chambers 40, 42, 44, 46 and 48 are substantially similar, such that only the flow balance pump chamber “A” 40 shall be described in detail.


Furthermore, the two inlet valves 50 and the two outlet valves 52 are substantially similar, such that only one inlet valve 50 and one outlet valve 52 shall be described in detail.


Referring back to FIG. 1, the flow balance pump chamber “A” 40 and inlet and outlet valves 50, 52 are defined between respective concave cavities 34 formed in the rigid body 31 of the cartridge 30 and the flexible membrane of the cartridge 32. The cartridge 30 defines fluid pathways 28 between the flow balance pump chamber “A” 40 inlet and outlet valves 50, 52.


In use, the cartridge 30 is retained between the first platen 12 on a first side of the cartridge 30 and the second platen 14 on a second side of the cartridge 30. The second platen 14 has a cartridge engaging surface 15 and a non-cartridge engaging surface 17. Cavities 16 are defined within the cartridge engaging surface 15, which correspond to the concave cavities 34 on the cartridge 30. A fluid port 18 is defined in each of the concave cavities 16, fluidly connecting the cartridge engaging surface 15 and the non-cartridge engaging surface 17, of the second platen 14.


The pneumatic actuators 24 are arranged in fluid communication with the first side of the cartridge 30, through the second platen 14 via the fluid ports 18, and hence the machine facing surface 33 of the flexible membrane 32. The pump chambers and valves are operated pneumatically by actuating the flexible membrane 32 using the pneumatic actuators 24 provided in the machine body 22. In an alternative embodiment the pump chambers and valves are operated hydraulically.


Sensing Arrangement

The pump chambers and valves are provided with sensing arrangements 60, each of which include two sensing electrodes, generally termed 70 (see FIGS. 4 and 5). The sensing electrodes 70 are rotationally symmetrical and are made of a conductive material. The sensing electrodes 70 include a pointed tip 71. The sensing electrodes 70 are mounted in the rigid body 31 of the cartridge 30. The pointed tip 71 is arranged to face the second side of the cartridge 30 and the flexible membrane 32.


The sensing arrangements 60 monitor the flow of fluids through the pump chambers and valves along the various fluid pathways. Referring to FIG. 6, one such fluid pathway is the fluid pathway 28 associated with the flow balance pump chamber “B” 42. As the sensing arrangements 60 are substantially similar, only the sensing arrangement 60 associated with the flow balance pump chamber “B” 42 shall be described in detail.


Flow Balance Pump Chamber “B” Sensing Arrangement

The flow balance pump chamber “B” sensing arrangement 60 is arranged with an inlet valve sensing electrode 72 and outlet valve sensing electrode 82. The inlet valve sensing electrode 72 is fixed to the rigid body 31 of the cartridge 30 with the pointed sensing tip 71 exposed to the fluid flowpath 28 at the entrance to the inlet valve 50. The outlet valve sensing electrode 82 is fixed to the rigid body 31 of the cartridge 30 with the pointed sensing tip 71 exposed to the fluid flowpath 28 at the exit of the outlet valve 52.


Thus the inlet valve sensing electrode 72 is provided upstream of the flow balance pump chamber “B” 42, and outlet valve sensing electrode 82 is provided downstream of the flow balance pump chamber “B” 42.


When the cartridge 30 is loaded into the dialysis machine 10, the inlet valve sensing electrode 72 and outlet valve sensing electrode 82 line up with sprung contacts 90, 94 provided in the second platen 14, sandwiching the flexible membrane 32 therebetween.


The sprung contacts 90, 94 are electrically connected to a processor 98, incorporating a sensor circuit, a comparator and a power source, provided in the machine body 22 via electrical connectors 92, 96 respectively.


Thus inlet valve sensing electrode 72 and outlet valve sensing electrode 82 are electrically connected to the processor 98 through the flexible membrane 32. The inlet valve sensing electrode 72 and outlet valve sensing electrode 82, together with the sprung contacts 90, 94, processor 98 and respective connectors 92, 96 form the sensing arrangement 60.


Valve Function

In use at least one of the inlet valve 50 and the outlet valve 52 will always be closed. That is, there are three modes of operation. In an idle mode, both the inlet valve 50 and the outlet valve 52 are closed. Thus there should be no continuous flowpath between the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82.


In a fill mode, the inlet valve 50 is open, and the outlet valve 52 is closed. This allows flow balance pump chamber “B” to be filled. However, there should still be no continuous flowpath between the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82, as the outlet valve is closed. In an empty mode, the inlet valve 50 is closed, and the outlet valve 52 is open. This allows flow balance pump chamber “B” to be emptied. However, there should still be no continuous flowpath between the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82, as the inlet valve 50 is closed. Thus the valve leak system may detect when either of the inlet or outlet valves 50, 52 are leaking using the sensing arrangement 60 shown in FIG. 6.


Valve Leak Detection System, Using Sensing Arrangement

During operation of the dialysis machine 10, the sensing arrangements 60 are used to detect leakage across the pump chambers and valves of the Dialysis Machine.


The sensor circuit of the processor 98, includes an operational amplifier based relaxation oscillator whose frequency is determined by electrical conductance of the fluid path.


In use, an alternating potential difference from the power source is applied across the fluid flowpath 28 by the inlet valve sensing electrode 72. The conductance of the fluid flowpath 28 between the inlet valve 50 and outlet valve 52 of the flow balance pump chamber “B” 42 is measured at the outlet valve sensing electrode 82 by measuring the potential difference detected at the outlet valve sensing electrode 82, as will be described in more detail below. The potential differential provides an indication the conductivity of the fluid flowpath 28. The relaxation oscillator ensures that the sensing arrangement 60 operates with an alternating current with minimal direct current offset. This reduces the galvanic effects on the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82.


The sensor circuit of the processor 98 generates the pulse train from the relaxation oscillator which is sent through the sensing arrangement 60, to output at the processor 98. The output at the processor is a series of pulses. From this series of pulses, a frequency is determined by measuring the time between the pulses, and hence fluid conductivity. This frequency value is known as the valve leak frequency.


The sensing arrangement 60 detects a valve leak in the inlet and outlet valves 50, 52 of the flow balance chamber “B” 42 by performing conductivity checks during operation of the flow balance system. The conductivity along a flow path should not exceed a defined limit if the flow path is interrupted by valves 50, 52. The test is performed once every pump operation. If the inlet or outlet valves 50, 52 fail to close, then the respective pump may draw or expel the fluid associated with that pump the wrong way, which is undesirable. The protective system for this error uses conductivity of the fluid flowpath 28 as a means to determine this failure. Thus in normal operation of the Dialysis Machine, there should never be a conductive path across the whole of the pump, from before the inlet valve 50 to after the outlet valve 52, that has a conductivity of a value equal to or greater than a limit value set by the particular geometry of the cartridge in question. If a conductive path is seen, this may be indicative of one of the valves 50, 52 having failed to close.


Hence the valve leak detection system measures a valve leak frequency value. The valve leak signal is generated by an oscillator and the frequency of the signal is determined by the feedback resistor. The sensing electrodes are connected in parallel to the feedback resistor so that a lower impedance across the valves would cause the total feedback resistor value to decrease, increasing the oscillating frequency.


During normal operation of an exemplary Dialysis Machine having an exemplary cartridge, the relaxation oscillator is tuned to generate a signal of 6 kHz for a resistance of 10 kOhms across the sensing electrodes. The expected detected valve leak frequency value is between 3 kHz and 4 kHz. Should a valve leak frequency value in excess of 6 kHz be detected, a valve leak has occurred.


Membrane Pump Usage Condition Detection

The valve leak detection system described above may be used to determine membrane pump usage and hence cartridge usage.


A partial valve leak (e.g. due to re-used cartridges) is detected when the variation of detected valve leak frequency value within a pumping cycle increases.


A variation in the detected valve leak frequency value is detected by the comparator within the processor 98 measuring the difference between the minimum and maximum valve leak frequency values measured within one pump cycle.


For the normal operation of an exemplary Dialysis Machine having an exemplary cartridge referred to above, variation of valve leak frequency value is between 200 Hz and 500 Hz. Variations above 1 kHz are considered to be partial valve leak. Thus for this exemplary Dialysis Machine having an exemplary cartridge, the pre-determined threshold value is a valve leak frequency value difference of 1 kHz.


The value used for the partial valve leak is not the absolute frequency but the variation of the frequency within a pumping cycle. When the valve is partially leaking (e.g. due to re-use of cartridges) the frequency signal is not as stable as it normally is: maximum relative difference of the valve leak frequency value within one pump cycle is more than 1 kHz. Normal expected values of absolute frequency are 3 kHz to 4 kHz with a variation of less than 1 kHz within a pumping cycle.


As the valve leak signal is generated by an oscillator and the frequency of the signal is determined by the feedback resistor, a dynamic threshold value for the valve leak frequency value difference may be used instead of the pre-determined threshold value.


The effects on a cartridge 30 during a dialysis treatment cycle can be represented by a typical test cycle. A typical test cycle includes three main stages, flow balance, ultrafiltration and purge. In the first 30 minutes, the dialysis machine 10 is taken through a flow balance stage of the test cycle. The flow balance stage tests the flow balance valves. During the next 30 minutes, the dialysis machine 10 is taken through an ultrafiltration stage of the test cycle. The ultrafiltration stage tests the ultrafiltration valves. The test cycle is then ended with a purge stage. The purge stage empties the cartridge 30 of all dialysate fluids, and cleans the fluid flow paths with reverse osmosis water.


In order to determine the deterioration rates, the same cartridge 30 is forced through repeated test cycles.


Valve Leak Frequency Profiles

With reference to FIG. 7, a valve leak frequency profile between inlet valve 50 and outlet valve 52, i.e. the fluid flowpath 28 across the flow balance chamber “B” 42, on a cartridge 30 undergoing a typical cycle is shown. The valve leak frequency values are measured every second, a comparison is made between the minimum and maximum valve leak frequency values and plotted as point readings 100 with respect to the Y-axis. A general distribution over the typical cycle time as shown on the X-axis. The first stage of the typical cycle represents the ultrafiltration stage 102 of the cycle, whereas the second stage of the typical cycle represents the flow balance stage 104 of the cycle. During ultrafiltration the blood pump is stopped at 106 and re-started at 108. Similarly, during flow balance, the blood pump is stopper at 110 and re-started at 112.


As can be seen in FIG. 7, whilst the measured valve leak frequency difference varies during a normal treatment session, the magnitude of any single difference value 100 does not exceed 900 Hz. The typical value throughout the cycle for valve leak frequency difference is between 200 Hz and 500 Hz. A spike 114 in the measured valve leak frequency difference value is seen during the ultrafiltration stage 102 of the cycle, the spike 114 reaching a maximum value of approximately 830 Hz.


With reference to FIG. 8, a cartridge 30 is taken through a series of five typical cycles, numbered as first cycle 200, second cycle 210, third cycle 220, fourth cycle 230 and fifth cycle 240. For each cycle, the valve leak frequency difference values are again plotted as point readings with respect to the Y-axis giving a general distribution over the typical cycle time as shown on the X-axis. Each cycle 200, 210, 220, 230, 240 includes an ultrafiltration stage 202, 212, 222, 232, 242, a flow balance stage 204, 214, 224, 234, 244, and a purge stage. The purge stage follows the flow balance stage 204, 214, 224, 234, 244 for each of the cycles 200, 210, 220, 230, 240 respectively.


The valve leak frequency difference limit 250 is shown as a dashed line at 1000 Hz. The valve leak frequency difference limit 250 may be manipulated depending on the deterioration rates displayed by the cartridge 30.


An increase in the valve leak frequency difference values can be seen from the first cycle 200 to the second cycle 210. This increase in the valve leak frequency difference value represents a deterioration in the flexible membrane of the cartridge. A yet greater increase in the valve leak frequency difference values is seen from the second cycle 210 to the third cycle 220. An alarm is raised during the third cycle 220, as the point readings regularly breach the 1000 Hz valve leak frequency difference limit 250.


Thus FIG. 8 shows that the valve leak frequency difference values increase over several cycles with the method described above, with the rate of deterioration being worse after each re-use, until the flexible membrane is effectively plastically deformed. Further re-use of the same cartridge will thus prevent meaningful treatment sessions, as evidenced in the fourth and fifth cycles 230, 240.


With reference to FIG. 9, a cartridge 30 is taken through a series of five typical cycles, numbered as first cycle 300, second cycle 310, third cycle 320 and fourth cycle 330. For each cycle, the valve leak frequency difference values are again plotted as point readings with respect to the Y-axis giving a general distribution over the typical cycle time as shown on the X-axis. Each cycle 300, 310, 320, 330 includes an ultrafiltration stage 302, 312, 322, 332, and a flow balance stage 304, 314, 324, 334, respectively, however, unlike in FIG. 8, no purge stage. Instead, the dialysis machine 10 is switched off just before the purge stage.


The valve leak frequency difference limit 350 is shown as a dashed line at 1000 Hz.



FIG. 9 shows that the degree of cartridge 30 deterioration is minimal if the purge stage is avoided, thereby allowing an alternative method to re-use the cartridge if necessary. This method of ageing the cartridge 30 does not appear to cause any noticeable deterioration.


Thus the method of determining a cartridge usage condition records the valve leak frequency during the cycle to obtain a characteristic value, and determines the cartridge usage condition based on the characteristic value. The characteristic value may be a single breach of the 1000 Hz valve leak frequency difference limit 250. The characteristic value may be a discreet number of breaches of the 1000 Hz valve leak frequency difference limit 250. The characteristic value may be a decay rate of the valve leak frequency difference following a spike in the valve leak frequency difference. The characteristic value may be the mean, median or modal average valve leak frequency difference during the cycle. The processor 98 may be programmed to monitor any of the preceding characteristic values. On receipt of a characteristic value, the process may send a signal to a graphical user interface, or to an audible or visual alarm to indicate the cartridge usage condition or a signal to prevent activation of the dialysis machine cycle.


Thus the detection system is sensitive enough so that it detects a deterioration of the cartridge membrane before a leak across the valve is established. This allows an operator to prevent use of a cartridge not fit for purpose.


Although the valve leak frequency is described as being measured using the sensing arrangements including sensing electrodes, other sensing arrangements are envisaged. A capacitance probe, which provides a non-contacting fluid flowpath sensing arrangement, is also envisaged, as is an inductance probe which is non-contacting. Other relaxation oscillator types may be used, such as a transistor based relaxation oscillator.

Claims
  • 1. A system for detecting a usage condition of a membrane pump, the system comprising: a cartridge including a rigid body and a deformable membrane, the rigid body and the deformable membrane together defining at least a portion of the membrane pump including a chamber and at least one valve in fluid communication with one another along a flow path defined by the cartridge, the at least one valve operable to open and close the flow path extending through the chamber of the membrane pump;a measuring device;a comparator;a signal generator, wherein: the measuring device is configured to determine a value of an electrical characteristic between two points on the flow path of the cartridge, a first point on the flow path upstream of the at least one valve and a second point on the flow path downstream of the at least one valve,the measuring device measures the value of the electrical characteristic when the at least one valve is closed,the comparator is configured to monitor the value of the electrical characteristic, andthe signal generator is arranged to provide an output signal, corresponding to the usage condition of the membrane pump, when the value of the electrical characteristic is indicative of deterioration of the membrane pump; anda processor arranged to receive the output signal comprising an error message for prevention of further use of the cartridge.
  • 2. The system according to claim 1, wherein the electrical characteristic is one of conductance, impedance or capacitance.
  • 3. The system according to claim 1, wherein the output signal is stored in the processor.
  • 4. A system for detecting a usage condition of a membrane pump the system comprising: a cartridge including a rigid body and a deformable membrane, the rigid body and the deformable membrane together defining at least a portion of the membrane pump including a chamber and at least one valve in fluid communication along a flow path defined by the cartridge, the at least one valve operable to open and close the flow path extending through the chamber of the membrane pump;a measuring device;a comparator;a signal generator, wherein: the measuring device is configured to determine a value of an electrical characteristic between two points on the flow path of the cartridge, a first point on the flow path arranged upstream of the at least one valve and a second point on the flow path arranged downstream of the at least one valve,the measuring device measures the value of the electrical characteristic when the at least one valve is closed,the comparator is configured to monitor the value of the electrical characteristic,andthe signal generator is arranged to provide an output signal, corresponding to the usage condition of the membrane pump, when the value of the electrical characteristic is indicative of deterioration of the membrane pump;
  • 5. The system according to claim 1, wherein the comparator compares the value of the electrical characteristic with a pre-determined threshold value thereof.
  • 6. The system according to claim 5, wherein the output signal is provided when the value of the electrical characteristic is above the pre-determined threshold value or falls below the pre-determined threshold value.
  • 7. A system for detecting a usage condition of a membrane pump, the system comprising: a cartridge including a rigid body and a deformable membrane, the rigid body and the deformable membrane together defining at least a portion of the membrane pump including a chamber and at least one valve in fluid communication with one another along a flow path defined by the cartridge, the at least one valve operable to open and close the flow path extending through the chamber of the membrane pump;a measuring device;a comparator;a signal generator, wherein: the measuring device is configured to determine a value of an electrical characteristic between two points on the flow path of the cartridge, a first point on the flow path upstream of the at least one valve and a second point on the flow path downstream of the at least one valve,the measuring device measures the value of the electrical characteristic when the at least one valve is closed,the comparator is configured to monitor the value of the electrical characteristic, andthe signal generator is arranged to provide an output signal, corresponding to the usage condition of the membrane pump, when the value of the electrical characteristic is indicative of deterioration of the membrane pump;
  • 8. The system according to claim 1, wherein the measuring device includes a pair of electrodes or a pair of capacitance probes.
  • 9. A method of determining a usage condition of a membrane pump, the method comprising the steps of: providing a dialysis machine including a cartridge, a measuring device, a comparator, and a signal generator, the cartridge having a rigid body and a deformable membrane, the rigid body and the deformable membrane together defining at least a portion of the membrane pump including a chamber and at least one valve in fluid communication with one another along a flow path defined by the cartridge, the at least one valve operable to open and close the flow path extending through the chamber of the membrane pump;configuring the measuring device for determining a value of an electrical characteristic between two points on the flow path of the cartridge, a first point on the flow path upstream of the at least one valve and a second point on the flow path downstream of the at least one valve;operating the dialysis machine through a cycle;with the at least one valve closed, measuring the value of the electrical characteristic;monitoring the value of the electrical characteristic throughout the cycle using the comparator;
  • 10. The method according to claim 9, wherein the electrical characteristic is one of conductance, impedance or capacitance.
  • 11. The method according to claim 9, wherein: the step of monitoring the value of the electrical characteristic includes recording the value of the electrical characteristic upon the value being above a limit value, or recording a series of values of the electrical characteristic above a limit value,ora recording a decay rate of a leak frequency difference of the at least one valve following a spike in the valve frequency difference of the at least one valve, and the decay rate is indicative of a specific number of uses of the cartridge.
  • 12. The method according to claim 9, wherein: the value of the electrical characteristic is a decay rate of a valve difference in leak frequency of the at least one valve following a spike in the difference in leak frequency of the at least one valve, and the decay rate is indicative of a specific number of uses of the cartridge,orthe value of the electrical characteristic is a mean, median or modal average of the difference in leak frequency of the at least one valve during the cycle.
  • 13. The method according to claim 9, wherein a valve leak frequency is recorded at a sample rate of 1 sample per second during the cycle.
  • 14. The method according to claim 9, wherein a valve leak frequency is recorded at an intermittent sample rate during the cycle.
  • 15. A dialysis machine comprising the system according to claim 1.
  • 16. A method of determining a usage condition of a membrane pump, the method comprising the steps of: providing a dialysis machine including a cartridge, a measuring device, a comparator, and a signal generator, the cartridge having a rigid body and a deformable membrane, the rigid body and the deformable membrane together defining at least a portion of the membrane pump including a chamber and at least one valve in fluid communication with one another along a flow path defined by the cartridge, the at least one valve operable to open and close the flow path extending through the chamber of the membrane pump;configuring the measuring device for determining a value of an electrical characteristic between two points on the flow path of the cartridge, a first point on the flow path upstream of the at least one valve and a second point on the flow path downstream of the at least one valve;operating the dialysis machine through a cycle;with the at least one valve closed, measuring the value of the electrical characteristic;monitoring the value of the electrical characteristic throughout the cycle using the comparator;providing an output signal, corresponding to the usage condition of the membrane pump, when the value of the electrical characteristic is indicative of deterioration of the membrane pump;andbased on the value of the electrical characteristic, calculating a specific number of uses of the cartridge.
  • 17. The system of claim 1, wherein the error message prevents activation of a cycle of a dialysis machine into which the cartridge is inserted.
Priority Claims (1)
Number Date Country Kind
1602391 Feb 2016 GB national
PCT Information
Filing Document Filing Date Country Kind
PCT/GB2017/050235 1/31/2017 WO
Publishing Document Publishing Date Country Kind
WO2017/137723 8/17/2017 WO A
US Referenced Citations (240)
Number Name Date Kind
2696173 Thormod Dec 1954 A
3338171 Conklin et al. Aug 1967 A
3468261 Schmierer Sep 1969 A
3605566 Vetter Sep 1971 A
3606592 Madurski et al. Sep 1971 A
3753493 Mellor Aug 1973 A
3774762 Lichtenstein Nov 1973 A
3807906 Breit Apr 1974 A
3921622 Cole Nov 1975 A
3972320 Kalman Aug 1976 A
4070725 Cornelius Jan 1978 A
4142845 Lepp et al. Mar 1979 A
4161264 Malmgren Jul 1979 A
4205686 Harris et al. Jun 1980 A
4353990 Manske et al. Oct 1982 A
4366061 Papanek et al. Dec 1982 A
4368261 Klose et al. Jan 1983 A
4370983 Lichtenstein Feb 1983 A
4430048 Fritsch Feb 1984 A
4494912 Pauliukonis Jan 1985 A
D277991 Becker Mar 1985 S
4534755 Calvert et al. Aug 1985 A
4534756 Nelson Aug 1985 A
4546669 Fischer et al. Oct 1985 A
4564342 Weber et al. Jan 1986 A
4599165 Chevallet Jul 1986 A
4648869 Bobo, Jr. Mar 1987 A
4666598 Heath et al. May 1987 A
4710163 Butterfield Dec 1987 A
4771792 Seale Sep 1988 A
4828543 Weiss et al. May 1989 A
4897184 Shouldice et al. Jan 1990 A
D308249 Buckley May 1990 S
4969991 Valadez Nov 1990 A
5000664 Lawless et al. Mar 1991 A
5012197 Seiffert et al. Apr 1991 A
5032265 Jha et al. Jul 1991 A
5055198 Shettigar Oct 1991 A
5095910 Powers Mar 1992 A
5103211 Daoud et al. Apr 1992 A
5126831 Nakagawara Jun 1992 A
5232434 Inagaki et al. Aug 1993 A
5252213 Ahmad et al. Oct 1993 A
D341890 Sievert et al. Nov 1993 S
D344339 Yoshikawa et al. Feb 1994 S
5304349 Polaschegg Apr 1994 A
D347896 Dickinson et al. Jun 1994 S
D351470 Scherer et al. Oct 1994 S
5385540 Abbott et al. Jan 1995 A
5421823 Kamen et al. Jun 1995 A
5458468 Ye et al. Oct 1995 A
5476368 Rabenau et al. Dec 1995 A
5476792 Ezrielev et al. Dec 1995 A
D370979 Pascale et al. Jun 1996 S
5558347 Nicholson Sep 1996 A
5586872 Skobelev et al. Dec 1996 A
5586873 Novak et al. Dec 1996 A
5591344 Kenley et al. Jan 1997 A
5643201 Peabody et al. Jul 1997 A
5650071 Brugger et al. Jul 1997 A
5653456 Mough Aug 1997 A
5658456 Kenley et al. Aug 1997 A
5665307 Kirschner et al. Sep 1997 A
5727550 Montecalvo Mar 1998 A
D395085 Kenley et al. Jun 1998 S
5788851 Kenley et al. Aug 1998 A
5807322 Lindsey et al. Sep 1998 A
5882300 Malinouskas et al. Mar 1999 A
5948247 Gillerfalk et al. Sep 1999 A
5957670 Duncan et al. Sep 1999 A
5995910 Discenzo Nov 1999 A
6077443 Goldau Jun 2000 A
6126831 Goldau et al. Oct 2000 A
6132378 Marino Oct 2000 A
6143181 Falkvall et al. Nov 2000 A
6153102 Kenley et al. Nov 2000 A
6216029 Paltieli Apr 2001 B1
6218329 Singh et al. Apr 2001 B1
6251279 Peterson et al. Jun 2001 B1
6261065 Nayak et al. Jul 2001 B1
6303036 Collins et al. Oct 2001 B1
6382923 Gray May 2002 B1
6514462 Simons Feb 2003 B1
6558347 Jhuboo et al. May 2003 B1
6582206 Schluecker Jun 2003 B2
6626832 Paltieli et al. Sep 2003 B1
6626878 Leisner et al. Sep 2003 B1
6645176 Christenson et al. Nov 2003 B1
6663829 Kjellstrand Dec 2003 B1
6733476 Christenson et al. May 2004 B2
6743204 Christenson et al. Jun 2004 B2
6801646 Pena et al. Oct 2004 B1
6814547 Childers et al. Nov 2004 B2
6967002 Edgson et al. Nov 2005 B1
7040142 Burbank May 2006 B2
7107837 Lauman Sep 2006 B2
7153286 Busby et al. Dec 2006 B2
7220358 Schacht et al. May 2007 B2
7284964 McDowell et al. Oct 2007 B2
7383721 Parsons Jun 2008 B2
7434312 Christenson et al. Oct 2008 B2
7494590 Felding et al. Feb 2009 B2
7604398 Akers et al. Oct 2009 B1
7648627 Beden et al. Jan 2010 B2
7857976 Bissler et al. Dec 2010 B2
7874999 Busby Jan 2011 B2
7896197 Furey et al. Mar 2011 B2
D641882 Hickey et al. Jul 2011 S
8114043 Muller Feb 2012 B2
8132388 Nagy et al. Mar 2012 B2
8137184 Ajiro et al. Mar 2012 B2
8137300 Han et al. Mar 2012 B2
8167431 DeCusatis et al. May 2012 B2
8187184 Muller et al. May 2012 B2
8192388 Hogard Jun 2012 B2
8197431 Bennison Jun 2012 B2
8221320 Bouton Jul 2012 B2
8348850 Frinak et al. Jan 2013 B2
8360977 Marttila et al. Jan 2013 B2
8529490 Wariar et al. Sep 2013 B2
8535522 Fulkerson et al. Sep 2013 B2
8535525 Heyes et al. Sep 2013 B2
D693469 Chung et al. Nov 2013 S
8597505 Fulkerson et al. Dec 2013 B2
D702842 Hyde et al. Apr 2014 S
8685244 Heyes et al. Apr 2014 B2
8696571 Marttila et al. Apr 2014 B2
8708908 Bouton Apr 2014 B2
8708946 Han et al. Apr 2014 B2
D705432 Lura et al. May 2014 S
8798908 Bourdeaut Aug 2014 B2
8801646 Han et al. Aug 2014 B2
D714454 Amemiya et al. Sep 2014 S
D714946 Lura et al. Oct 2014 S
8926544 Hogard et al. Jan 2015 B2
D724740 Collins et al. Mar 2015 S
8974394 Frinak et al. Mar 2015 B2
9011334 Bouton Apr 2015 B2
D735868 Mareguddi et al. Aug 2015 S
9220825 Buckberry Dec 2015 B2
D781410 Ritter et al. Mar 2017 S
9744285 Heyes et al. Aug 2017 B2
9833553 Higgitt Dec 2017 B2
10314962 Buckberry Jun 2019 B2
10456516 Heyes et al. Oct 2019 B2
D867597 Bauer et al. Nov 2019 S
10543305 Buckberry et al. Jan 2020 B2
D879967 Verguidi et al. Mar 2020 S
D907211 Spurling Jan 2021 S
10881775 Wallace Jan 2021 B2
10960120 Wallace Mar 2021 B2
D924410 Mendoza et al. Jul 2021 S
D938046 Gupta et al. Dec 2021 S
11365728 Westenbrink Jun 2022 B2
11571499 Milad et al. Feb 2023 B2
11583618 Buckberry et al. Feb 2023 B2
20030217962 Childers et al. Nov 2003 A1
20040195157 Mullins et al. Oct 2004 A1
20040206703 Bosetto et al. Oct 2004 A1
20040215129 Edgson et al. Oct 2004 A1
20040223857 Kline Nov 2004 A1
20050020961 Burbank et al. Jan 2005 A1
20050205476 Chevallet et al. Sep 2005 A1
20050209547 Burbank et al. Sep 2005 A1
20050234384 Westberg Oct 2005 A1
20060121623 He et al. Jun 2006 A1
20070083193 Werneth et al. Apr 2007 A1
20080006089 Adnan Jan 2008 A1
20080200865 Bedingfield Aug 2008 A1
20080283096 Scheringer et al. Nov 2008 A1
20090007642 Busby et al. Jan 2009 A1
20090009290 Kneip et al. Jan 2009 A1
20090012450 Shah et al. Jan 2009 A1
20090012452 Slepicka et al. Jan 2009 A1
20090012457 Childers et al. Jan 2009 A1
20090101550 Muller et al. Apr 2009 A1
20090211975 Brugger et al. Aug 2009 A1
20090230043 Heyes et al. Sep 2009 A1
20100043694 Patel Feb 2010 A1
20100045471 Meyers Feb 2010 A1
20100089807 Heyes et al. Apr 2010 A1
20100139254 Sebestyen et al. Jun 2010 A1
20100263687 Braun et al. Oct 2010 A1
20110009797 Kelly et al. Jan 2011 A1
20110034850 Jonsson Feb 2011 A1
20110132838 Curtis et al. Jun 2011 A1
20110168614 Pouchoulin et al. Jul 2011 A1
20120164022 Muginstein et al. Jun 2012 A1
20120269907 Coates Oct 2012 A1
20120276549 Cunningham et al. Nov 2012 A1
20120292237 Heyes et al. Nov 2012 A1
20120308431 Kotsos et al. Dec 2012 A1
20130037465 Heyes et al. Feb 2013 A1
20130056419 Curtis Mar 2013 A1
20130153495 Kelly et al. Jun 2013 A1
20130199998 Kelly et al. Aug 2013 A1
20130274642 Soykan et al. Oct 2013 A1
20140224736 Heide Aug 2014 A1
20140251885 Heyes Sep 2014 A1
20140271106 Alessandro Sep 2014 A1
20140299544 Wilt et al. Oct 2014 A1
20150027951 Wallace Jan 2015 A1
20150076053 Higgitt Mar 2015 A1
20150112119 Buckberry Apr 2015 A1
20150129481 Higgitt et al. May 2015 A1
20150238673 Gerber et al. Aug 2015 A1
20150258263 Hogard Sep 2015 A1
20150352269 Gerber et al. Dec 2015 A1
20150359954 Gerber et al. Dec 2015 A1
20160045656 Buckberry Feb 2016 A1
20160051743 Buckberry Feb 2016 A1
20160058933 Ballantyne et al. Mar 2016 A1
20160076535 Clifton Mar 2016 A1
20160077644 Ritter et al. Mar 2016 A1
20160199558 Buckberry Jul 2016 A1
20170056576 Doyle et al. Mar 2017 A1
20170167983 Klomp et al. Jun 2017 A1
20170252498 Heyes et al. Sep 2017 A1
20170296730 Soto et al. Oct 2017 A1
20180133391 Heyes et al. May 2018 A1
20180154059 Heyes et al. Jun 2018 A1
20180193545 Crnkovich et al. Jul 2018 A1
20180344915 Wallace Dec 2018 A1
20190001042 Buckberry Jan 2019 A1
20190015577 Garrido et al. Jan 2019 A1
20190024654 May Jan 2019 A1
20190358381 Westenbrink Nov 2019 A1
20190374698 Buckberry et al. Dec 2019 A1
20190376504 Westenbrink Dec 2019 A1
20190385434 Yuds et al. Dec 2019 A1
20200030515 Merchant Jan 2020 A1
20200075159 Bardorz et al. Mar 2020 A1
20200268958 Heyes et al. Aug 2020 A1
20200276372 Milad et al. Sep 2020 A1
20200330671 Buckberry et al. Oct 2020 A1
20210110920 Heyes et al. Apr 2021 A1
20220001087 Heyes et al. Jan 2022 A1
20220160943 Buckberry et al. May 2022 A9
20220241480 Fincham Aug 2022 A1
20220241573 Fincham Aug 2022 A1
Foreign Referenced Citations (67)
Number Date Country
81430 Aug 1997 CA
10024447 Nov 2001 DE
004375764-0001 Oct 2017 EA
004375764-0002 Oct 2017 EA
007955125-0002 Jun 2020 EA
0165751 Dec 1985 EP
0754468 Jan 1997 EP
2219703 Aug 2010 EP
2955512 Dec 2015 EP
2 310 136 Dec 1976 FR
9007955125-0001 May 2020 GB
9007955125-0002 May 2020 GB
H04266740 Feb 1991 JP
H06261872 Sep 1994 JP
H06261872 Sep 1994 JP
H07174659 Jul 1995 JP
2000130334 May 2000 JP
D1645323 Nov 2020 JP
WO 8101800 Jul 1981 WO
WO 9100113 Jan 1991 WO
WO 9116542 Oct 1991 WO
1995006205 Mar 1995 WO
WO 9525893 Sep 1995 WO
WO 9625214 Aug 1996 WO
WO 9710013 Mar 1997 WO
WO 9728368 Aug 1997 WO
WO 9929356 Jun 1999 WO
WO 2000006217 Feb 2000 WO
WO 0057935 Oct 2000 WO
WO 02066833 Aug 2002 WO
WO 02081917 Oct 2002 WO
WO 2003101510 Dec 2003 WO
WO 2005044339 May 2005 WO
WO 2005080794 Sep 2005 WO
WO 2006120415 Nov 2006 WO
WO 2006120417 Nov 2006 WO
WO 2008100671 Aug 2008 WO
WO 2008106191 Sep 2008 WO
WO 2008135245 Nov 2008 WO
WO 2009006489 Jan 2009 WO
WO 2009024333 Feb 2009 WO
WO 2009038834 Mar 2009 WO
WO 2009061608 May 2009 WO
WO 2009127624 Oct 2009 WO
WO 2010089130 Aug 2010 WO
WO 2010146343 Dec 2010 WO
WO 2011027118 Mar 2011 WO
WO 2011068885 Jun 2011 WO
WO 2011105697 Sep 2011 WO
WO 2011105698 Sep 2011 WO
WO 2013052680 Apr 2013 WO
WO 2013057109 Apr 2013 WO
WO 2013110906 Aug 2013 WO
WO 2013110919 Aug 2013 WO
WO 2013114063 Aug 2013 WO
WO 2013121162 Aug 2013 WO
WO-2013110906 Aug 2013 WO
WO-2013110919 Aug 2013 WO
WO-2013121163 Aug 2013 WO
WO 2014072195 May 2014 WO
WO 2014082855 Jun 2014 WO
WO 2014155121 Oct 2014 WO
WO 2015007596 Jan 2015 WO
WO 2015022537 Feb 2015 WO
WO 2016016870 Feb 2016 WO
WO-2017137723 Aug 2017 WO
WO-2018115816 Jun 2018 WO
Non-Patent Literature Citations (12)
Entry
International Search Report and Written Opinon issued for International Application No. PCT/GB2017/050235, dated Apr. 10, 2017.
Search Report issued for GB1602391.3, dated Sep. 16, 2016.
Ergo-Express Motorized Dialysis Cart, Aug. 14, 2017, youtube.com [online], [site visited Jan. 9, 2022], Available from internet, URL: <https://www.youtube.com/watch?v=j4rAXthOmbY> (Year: 2017).
He et al., “A Fluorescent Sensor with High Selectivity and Sensitivity for Potassium in Water,” Journal of the American Chemical Society 2003 125 (6), 1468-1469.
Home Dialysis Tescon Aqua Tech, Aug. 1, 2020, youtube.com [online], [site visited Jan. 9, 2022], Available from internet, URL: <https:// www.youtube.com/watch?v=WLLPZoS_mz4> (Year: 2020).
Kivi, Air Embolism, Healthline, Aug. 20, 2012, p. 1-5.
LHO2028 Portable Hemodialysis Machine, date unknown, aliexpress.com [online], [site visited Jan. 4, 2022], Available from internet: <https ://www.aliexpress.com/item/1005003324875329.html?randl_currency=USD&_randl_shipto=US&src=google&afffcid=1003bab3b8db4e93b9ba88522a14cfc1-1641319351626-05232-UneMJZVf&aff_fsk=UneMJZVf&aff_platform=aaf&sk=UneMJZVf&aff_trace_key= (Year: 2022).
Medical Hemodialysis Machine, date unknown, aliexpress.com [online], [site visited Jan. 4, 2022], Available from internet: <https://www.aliexpress.com/item/1005003445721549.html?_ randl_currency=USD&_randl_shipto=US&src=google&aff_fcid=a524f3f9cd9b4976b6b47962f3439d62-1641319166409-02691-UneMJZVf&aff_fsk=UneMJZVf&aff_platform=aaf&sk=UneMJZVf&aff_trace_key=a524f3f9cd9b4976b6b47962f3439d62-1641319166409-02691-UneMJZVf&terminal_id=d0c2cca4b7664d128cb4801 a9ef03ff2> (Year: 2022).
Millenium HX Portable Dialysis Water System, Jul. 2, 2014, youtube.com [online], [site visited Jan. 10, 2022], Available from internet, URL: <https://www.youtube.com/watch?v=IGEbPi2CDsw> (Year: 2014).
Portable home dialysis device, Nov. 2, 2017, med-technews.com [online], [site visited Jan. 4, 2022], Available from internet: <https://www.med-technews.com/news/portable-home-dialysis-device-to-launch-next-year/ (Year: 2017).
European Patent Office, “International Preliminary Report on Patentability,” issued in International Patent Application No. PCT/GB2017/053738, dated Jun. 25, 2019 (8 pages).
European Patent Office, “International Preliminary Report and Written Opinion,” issued in International Patent Application No. PCT/GB2017/053738, dated Feb. 27, 2018 (11 pages).
Related Publications (1)
Number Date Country
20190024654 A1 Jan 2019 US